FLSCFrazier Life Sciences Acquisition II (Stock-Only)
2026-incorporated blank check SPAC targeting business combinations in life sciences.
$10IPO price
$75MRaised
$10.29Day-1 close
2.90%Day-1 return
2026-incorporated blank check SPAC targeting business combinations in life sciences.
Company description (source: StockAnalysis)
Frazier Life Sciences Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.
51CFO read: CFO must navigate SPAC accounting (ASC 815), M&A due diligence, and life sciences target valuation.
Management details per the SEC prospectus.
Does your company need this kind of CFO?
51CFO matches you with Western CFOs who have each run a full US IPO — plus other C-level talent. First shortlist within 48 hours; free 30-minute listing-readiness read.
Talk to us